Development of an in vivo method to better understand the obese skin

Development of an in vivo method to better understand the obese skin

Jornal de Investigação Biomédica e Biofarmacêutica



Bibliographic data

Translated title: Desenvolvimento de um método in vivo para melhor compreender a pele do obeso
Journal Title: Jornal de Investigação Biomédica e Biofarmacêutica
First author: Liliana Tavares
Other Authors: Lídia Palma;
Mª Angélica Almeida;
Mª Julia Bujan;
Luís Monteiro Rodrigues
Palabras clave:
Traslated Keywords:
Language: English
Portuguese
Get full text: http://www.alies.pt/BBR%20Editions/Vol-9-1-2012/Article7_9n1.pdf
Resource type: Journal Article
Source: Jornal de Investigação Biomédica e Biofarmacêutica; Vol 9, No 1 (Year 2012).
DOI: http://dx.doi.org/10.19277/bbr.19.1.30
Publisher: Associação Lusófona para o Desenvolvimento da Investigação e Ensino em Ciências da Saúde
Usage rights: Reconocimiento - NoComercial (by-nc)
Categories: Life Sciences --> Biochemistry --AMP-- Molecular Biology
Health Sciences --> Pharmacology --AMP-- Pharmacy
Health Sciences, Life Sciences --> Physiology

Statistical data

  • Views
  • Consultations
  • Citation style
  • Share
  • Export record
  • Favourites
Bibliography: [1] Formiguera X, Cantón A. Obesity: epidemiology and clinical aspects. Best Practice & Research Clinical Gastroenterology Vol. 18, No. 6, pp. 1125–1146, 2004

[2] Yosipovich G, De Vore A, Dawn A. Obesity and skin: Skin physiology and skin manifestations of Obesity. J Am Acad Dermatol, 2007;6: 901-16.

[3] Nino M, Franzese A, Ruggiero Perrino N, Balato N. The Effect of Obesity on Skin Disease and Epidermal Permeability Barrier Status in Children. Pediatr Dermatol. 2012 Apr 4.

[4] Guida B, Nino M, Perrino NR, Laccetti R, Trio R, Labella S, Balato N, The impact of obesity on skin disease and epidermal permeability barrier status. J Eur Acad Dermatol Venereol. 2010 Feb;24(2):191-5. Epub 2009 Nov 19.

[5] Löffler H, Aramaki JU, Effendy I. The influence of body mass index on skin susceptibility to sodium lauryl sulphate. Skin Res Technol. 2002 Feb;8(1):19-22

[6] Matsuzawa Y, Shimomura I, Nakamura T, Keno Y, Kotani K, Tokunaga K. Pathophysiology and pathogenesis of visceral fat obesity. Obes Res. 1995 Sep;3 Suppl 2:187S-194S.

[7] Sebastian JL. Bariatric surgery and work-up of the massive weight loss patient. Clin Plast Surg. 2008 Jan; 35 (1):11-26

[8] Shermak MA, Rotellini-Coltvet LA, Chang D. Seroma development following body contouringsurgery for massive wheight loss: patient risk factos and treatment srtategies. Plast Reconstr Surg. 2008, Jul-, 122(1): 280-8

[9] WHO expert consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. The Lancet, 2004; 157-163.

[10] WHO, Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. WHO Technical Report Series 854. Geneva: World Health Organization, 1995

[11] Garrow JS, Welster J. Quetelet's index (W/H2) as a measure of fatness. Int J Obes 1985; 9: 147–153.

[12] República, Lei 46/2004 de 19 de Agosto.

[13] EUROPEAN DIRECIVE 2001/20/EC on the approximation of the laws, regulations and administrative provisions of the Member State relating to the implementation of good clinical practice in the conduct. Of clinical trials on medicinal products for human use, Off J Europ Communities, L121/34-44, 2001.

[14] Note for Guidance on Good Clinical Practice, ICH E6GCP96, EMEA, 2002: 1-55.

[15] World Medical Association declaration of Helsinky. Ethical Principles for Medical Research Involving Human subjects, amended until 2004 Rogiers V

[16] ; EEMCO Group. EEMCO guidance for the assessment of transepidermal water loss in cosmetic sciences. Skin Pharmacol Appl Skin Physiol 2001;14 (2):117-28.

[17] Piérard GE, EEMCO guidance to the in vivo assessment of tensile functional properties of the skin. Part 1: relevance to the structures and ageing of the skin and subcutaneous tissues. Skin Pharmacol Appl Skin Physiol. 1999;12(6):352-62

[18] Rodrigues L; EEMCO, EEMCO guidance to the in vivo assessment of tensile functional properties of the skin. Part 2: instrumentation and test modes. Skin Pharmacol Appl Skin Physiol. 2001;14(1):52-67.

[19] Darlenski R, Sassning S, Tsankov N, Fluhr JW. Non-invasive in vivo methods for investigation of the skin barrier physical properties. Eur J Pharm and Biopharm. 2009, 72:295-303